本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

SpringWorks Therapeutics, Inc.

44.51
-0.4250-0.95%
成交量:472.82万
成交额:2.11亿
市值:33.37亿
市盈率:-12.78
高:45.01
开:44.84
低:44.31
收:44.93
数据加载中...
2024/06/07

重要事件披露

Form 8-K - Current report
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

重要事件披露

Form 8-K - Current report
2023/12/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]